Replies to post #542012 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

Thanks for asking. Her most relevant background currently, as the P3 data were recently published, is her experience and expertise as a clinical trial expert. Is there anyone who is better suited to run an immunotherapy study and analyze clinical data? Research these facts: